Last update 12 Apr 2025

Neptinib Di-P-methylbenzenesulfonate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
EGFR
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
NeoplasmsMalignant Solid Neoplasm
Inactive Indication
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+ [1]
Originator Organization
Shenzhen Neptunus Pharmaceutical Research Institute Co. Ltd.Shenzhen Neptunus Pharmaceutical Research Institute Co. Ltd.
Active Organization
Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Pharmaceutical Research Institute Co. Ltd.Shenzhen Neptunus Pharmaceutical Research Institute Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationSpecial Review Project (China)
Login to view timeline

Related

100 Clinical Results associated with Neptinib Di-P-methylbenzenesulfonate
Login to view more data
100 Translational Medicine associated with Neptinib Di-P-methylbenzenesulfonate
Login to view more data
100 Patents (Medical) associated with Neptinib Di-P-methylbenzenesulfonate
Login to view more data
100 Deals associated with Neptinib Di-P-methylbenzenesulfonate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 1
United States
Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Bioengineering Co., Ltd.
30 Jan 2022
Malignant Solid NeoplasmIND Approval
China
Shenzhen Neptunus Pharmaceutical Research Institute Co. Ltd.Shenzhen Neptunus Pharmaceutical Research Institute Co. Ltd.
02 Jun 2011
Breast CancerIND Application
China
Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Bioengineering Co., Ltd.
12 Dec 2016
Colorectal CancerIND Application
China
Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Bioengineering Co., Ltd.
12 Dec 2016
Non-Small Cell Lung CancerIND Application
China
Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Bioengineering Co., Ltd.
12 Dec 2016
Stomach CancerIND Application
China
Shenzhen Neptunus Bioengineering Co., Ltd.Shenzhen Neptunus Bioengineering Co., Ltd.
12 Dec 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free